0001104659-24-071247.txt : 20240613
0001104659-24-071247.hdr.sgml : 20240613
20240613160119
ACCESSION NUMBER: 0001104659-24-071247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240611
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHLEIFER LEONARD S
CENTRAL INDEX KEY: 0001218629
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 241041165
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
tm2417175-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-11
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001218629
SCHLEIFER LEONARD S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
Bd. Co-Chair, President & CEO
1
Common Stock
157552
I
2023 GRAT
Common Stock
5932
I
By 401(k) Plan
Common Stock
2024-06-11
4
S
0
7321
1015.28
D
56877
I
By Trust
Common Stock
2024-06-11
4
S
0
1743
1016.04
D
55134
I
By Trust
Common Stock
2024-06-12
4
S
0
14879
1015.30
D
40255
I
By Trust
Common Stock
2024-06-12
4
S
0
270
1016.62
D
39985
I
By Trust
Common Stock
466877
D
Common Stock
2024-06-12
4
C
0
1000
0.00
A
1000
I
by Trust for Son
Common Stock
2024-06-12
4
S
0
1000
1025.27
D
0
I
by Trust for Son
Class A Stock
0.00
2024-06-12
4
C
0
1000
0.00
D
Common Stock
1000
14775
I
by Trust for Son
Class A Stock
0.00
Common Stock
1710790
1710790
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 5, 2024.
Represents volume-weighted average price of sales of 7,321 shares of common stock of Regeneron Pharmaceuticals, Inc. (the "Company") on June 11, 2024 at prices ranging from $1,015.00 to $1,015.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
Represents volume-weighted average price of sales of 1,743 shares of Company stock on June 11, 2024 at prices ranging from $1,016.04 to $1,016.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2024 at each separate price.
Represents volume-weighted average price of sales of 14,879 shares of Company stock on June 12, 2024 at prices ranging from $1,015.00 to $1,015.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
Represents volume-weighted average price of sales of 270 shares of Company stock on June 12, 2024 at prices ranging from $1,016.10 to $1,016.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
Represents volume-weighted average price of sales of 1,000 shares of Company stock on June 12, 2024 at prices ranging from $1,025.00 to $1,025.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2024 at each separate price.
Class A Stock of the Company converts to common stock of the Company on a one-to-one basis upon certain events or upon election of the shareholder.
These shares of Class A Stock are presently convertible and such conversion feature does not expire.
/s/**Leonard S. Schleifer
2024-06-13